Julie Dumont
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 5
- Peptidase Inhibition and Analysis 2
-
- Thyroid Disorders and Treatments 2
-
- Adipose Tissue and Metabolism 2
-
- Peroxisome Proliferator-Activated Receptors 4
- Chemical Synthesis and Analysis 3
-
- Computational Drug Discovery Methods 2
-
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 2
- Co-authors
- Bart StaelsSandrine CaronEmmanuel BouchaertBertrand CariouAnthony LucasEmilie DorchiesFolkert KuipersMouaadh Abdelkarim
- Journals
- European Journal of Medicinal Chemistry (2 papers)FEBS Letters (2 papers)SLAS DISCOVERY (1 paper)
- Partner nations
- FranceUnited KingdomNetherlands
In The Last Decade
Julie Dumont
19 papers receiving 785 citations
Peers
Comparison fields: 5 of 81
- Oncology 316
- Endocrinology, Diabetes and Metabolism 136
- Epidemiology 247
- Physiology 174
- Surgery 246
Countries citing papers authored by Julie Dumont
This map shows the geographic impact of Julie Dumont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Dumont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Dumont more than expected).
Fields of papers citing papers by Julie Dumont
This network shows the impact of papers produced by Julie Dumont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Dumont. The network helps show where Julie Dumont may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Julie Dumont, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 12 | |
| 4 | 2021 | 7 | |
| 5 | 2020 | 7 | |
| 6 | 2014 | 24 | |
| 7 | 2014 | 15 | |
| 8 | 2013 | 16 | |
| 9 | 2013 | 112 | |
| 10 | 2012 | 2 | |
| 11 | 2011 | 267 | |
| 12 | 2010 | 76 | |
| 13 | 2010 | 53 | |
| 14 | 2010 | 77 | |
| 15 | 2010 | 20 | |
| 16 | 2007 | 31 | |
| 17 | 1997 | 30 | |
| 18 | 1994 | 42 | |
| 19 | Mesosome like organelles in streptococcus mutans | 1983 | 2 |
| 20 | 1976 | 6 |
About Julie Dumont
Julie Dumont is a scholar working on Oncology, Developmental Neuroscience and Endocrinology, Diabetes and Metabolism, having authored 20 papers that have together received 800 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (5 papers), Peroxisome Proliferator-Activated Receptors (4 papers), Chemical Synthesis and Analysis (3 papers), Computational Drug Discovery Methods (2 papers), Adipose Tissue and Metabolism (2 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers), Peptidase Inhibition and Analysis (2 papers) and Thyroid Disorders and Treatments (2 papers). The work is most often cited by research in Oncology (316 citations), Endocrinology, Diabetes and Metabolism (136 citations) and Epidemiology (247 citations). Julie Dumont has collaborated with scholars based in France, United Kingdom and Netherlands. Frequent co-authors include Bart Staels, Sandrine Caron, Emmanuel Bouchaert, Bertrand Cariou, Anthony Lucas, Emilie Dorchies, Folkert Kuipers, Mouaadh Abdelkarim, Iuliana Popescu and Janne Prawitt. Their work appears in journals such as European Journal of Medicinal Chemistry, FEBS Letters, SLAS DISCOVERY, Endocrinology and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.